Abstract
- Population: 9-16 year-olds living in dengue endemic areas seronegative at vaccination
- Intervention: 3 doses of CYD-TDV administered 6 months apart
- Comparison: Placebo
- Outcome: Virologically-confirmed dengue occurring < 25 months of completion of the first dose (13 months post dose 3)
- GRADE table
- Dengue
